Summary & Overview
HCPCS A2030: Miro3d fibers, per milligram
HCPCS Level II code A2030 designates Miro3d fibers billed per milligram, a supply-line item used for specialized medical and laboratory applications. As a national-level billing code for measured fiber products, A2030 matters for suppliers, facilities, and payers managing procurement, inventory, and claims for procedure-related consumables.
Key payers included in this analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of billing and coverage context for this supply item, typical sites of service where A2030 is used, and the areas where benchmarking and policy review typically focus for HCPCS supply codes—such as allowable units, documentation requirements, and billing line practices.
This publication provides: a concise clinical description of the product represented by A2030, a summary of payer coverage presence and common billing considerations, and guidance on where to look for policy updates and claim processing guidance. Data not available in the input is noted where applicable.
Billing Code Overview
HCPCS Level II code A2030 represents Miro3d fibers, billed per milligram. This item is a supply item consisting of microfibers used in specialized medical or laboratory applications. The typical site of service for A2030 is outpatient clinic settings, ambulatory procedure centers, and hospital outpatient departments where specialized wound care, surgical adjuncts, or laboratory processing requires measured quantities of fiber material.
Service type: Medical supply / durable medical supply (per milligram unit)
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient receiving A2030 (Miro3d fibers, per milligram) is undergoing a procedure that requires implantation or augmentation with a specialized biomaterial composed of microfibrous matrix for soft-tissue support, wound bed modulation, or surgical reinforcement. Common settings include outpatient ambulatory surgical centers and hospital operating rooms where surgeons manage complex soft-tissue defects, reconstructive needs after trauma or tumor resection, or revision procedures for failed prior repairs. The clinical workflow begins with preoperative assessment and informed consent; intraoperatively, the surgeon measures the required milligram quantity of Miro3d fibers and documents lot numbers and quantity used. The product is opened and applied by the surgical team under sterile conditions, integrated into the repair (for example, layered into a wound bed, used to augment tendon or fascial repairs, or placed as an adhesion barrier). Postoperative documentation includes the exact A2030 quantity in milligrams used, indication for use, and any device-specific lot/serial documentation required by facility policy. Typical clinicians involved include general surgeons, plastic and reconstructive surgeons, orthopedic surgeons, and wound care specialists. Billing requires linkage of the billed A2030 units to the operative report and implant/device logs, and appropriate HCPCS coding practices for biomaterials billed by weight.
Coding Specifications
| Modifier | Description | When to Use |
|---|